Skip to main content
Premium Trial:

Request an Annual Quote

Idaho Technology, Applied Biosystems in Cross-licensing Deal

NEW YORK (GenomeWeb News) – Idaho Technology and Life Technologies' Applied Biosystems business have entered into a cross-licensing pact covering instrument, software, and reagents, Idaho Technology said today.

The licensing deal includes patents that relate to real-time polymerase chain reaction methods and instrumentation, including the 5' nuclease process SYBR Green I in PCR reactions. More specific details and financial terms of the agreement were not disclosed.

The cross-licensing pact "enables innovation in a more open environment that is good for business and ultimately benefits customers," Randy Rasmussen, president of Idaho Technology, said in a statement.

Salt Lake City-based Idaho Technology is privately held and licensed the rapid PCR technology from the University of Utah. It created the LightCycler PCR-based instrument, which it sublicensed to Roche Diagnostics.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.